IL2 and acute lymphoblastic leukemia: More recently, a similar NK-cell expansion efficiency was reported when NK cells from healthy donors or patients with ALL in CR were co-cultured with autologous PBMCs in CellGro SCGM medium containing IL-2 and IL-15 (respectively, 34.9- vs. 39.5-fold average expansion after 14 days) (89).